Commitments and Contingencies (Details Narrative) |
1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | 36 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 26, 2019
USD ($)
|
Sep. 13, 2018
USD ($)
|
Sep. 13, 2018
EUR (€)
|
Aug. 12, 2016
USD ($)
|
May 05, 2016
USD ($)
|
May 05, 2016
AUD ($)
|
May 04, 2016
USD ($)
|
Jun. 30, 2012 |
Jun. 30, 2018
USD ($)
|
Dec. 31, 2019
USD ($)
shares
|
Jun. 30, 2019
USD ($)
|
Jun. 30, 2018
USD ($)
|
Dec. 31, 2014
USD ($)
|
|
Penalty amount | $ 30,000 | ||||||||||||
Operating lease term | 5 years | ||||||||||||
Rent expense | $ 28,062 | $ 30,521 | |||||||||||
Contract cost | 49,854 | ||||||||||||
Royalties percentage | 2.00% | 2.00% | |||||||||||
Royalty Agreement Terms [Member] | |||||||||||||
Operating leases income statement revenue percentage | 2.00% | ||||||||||||
License Agreement Terms [Member] | |||||||||||||
Operating leases income statement revenue percentage | 5.00% | ||||||||||||
New Five-Year Operating Lease Agreement [Member] | |||||||||||||
Operating lease term | 5 years | 5 years | |||||||||||
Payments for rent | $ 2,469 | $ 2,325 | |||||||||||
New Five-Year Operating Lease Agreement [Member] | AUD Currency [Member] | |||||||||||||
Payments for rent | $ 3,606 | ||||||||||||
Manufacturing Services Agreement [Member] | Minimum [Member] | |||||||||||||
Anticipated milestone payment | $ 2,500,000 | ||||||||||||
Manufacturing Services Agreement [Member] | Maximum [Member] | |||||||||||||
Anticipated milestone payment | $ 5,000,000 | ||||||||||||
Amatsigroup Agreement [Member] | |||||||||||||
Payments description | The Company anticipates that its payments to Amatsigroup under the MSA will range between $2.5 million and $5.0 million over three years, when the finished drug product is manufactured and released for clinical trials. The Company has spent a total of $1,689,146 of costs to date under this contract of which $1,689,146 was expensed in prior years. The MSA shall continue for a term of three years unless extended by mutual agreement in writing. | ||||||||||||
Contract cost | $ 1,689,146 | $ 1,689,146 | $ 1,689,146 | ||||||||||
One-Year Collaboration Agreement [Member] | |||||||||||||
Payment for services | $ 59,508 | ||||||||||||
One-Year Collaboration Agreement [Member] | Euros [Member] | |||||||||||||
Payment for services | € | € 52,000 | ||||||||||||
Two-Year Collaboration Agreement [Member] | |||||||||||||
Payment for services | $ 45,775 | ||||||||||||
Two-Year Collaboration Agreement [Member] | Euros [Member] | |||||||||||||
Payment for services | € | € 40,000 | ||||||||||||
From 2012 through the 2014 [Member] | |||||||||||||
Penalty amount | $ 10,000 | 10,000 | |||||||||||
Regal Consulting, LLC [Member] | |||||||||||||
Loss contingency amount | $ 400,000 | ||||||||||||
Stock issued for the services, shares | shares | 60,000 | ||||||||||||
Foley Shechter [Member] | |||||||||||||
Legal fees | $ 151,032 |